Trial data support 3 shorter regimens for drug-resistant TB- Chris Dall, MA
A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New England Journal of Medicine. The phase 3…









